Kiser J, Seabury C, Neupane M, Moraes J, Herrick A, Dalton J
BMC Genomics. 2025; 26(1):174.
PMID: 39984840
PMC: 11846197.
DOI: 10.1186/s12864-025-11364-9.
Chan H, Ngan H, Ng Y, Law C, Poon P, Chan R
Cancers (Basel). 2025; 17(3).
PMID: 39941730
PMC: 11816149.
DOI: 10.3390/cancers17030361.
Gordy J, Bates R, Glass E, Meza J, Li Y, Schill C
Res Sq. 2025; .
PMID: 39877094
PMC: 11774437.
DOI: 10.21203/rs.3.rs-5663995/v1.
Stefanello S, Mizdal C, Silva A, Todesca L, Antunes Soares F, Shahin V
Discov Nano. 2025; 20(1):12.
PMID: 39836351
PMC: 11751257.
DOI: 10.1186/s11671-025-04184-z.
Zhu M, Li N, Fan L, Wu R, Cao L, Ren Y
Blood Cancer J. 2024; 14(1):218.
PMID: 39695118
PMC: 11655871.
DOI: 10.1038/s41408-024-01199-0.
Integrins in the kidney - beyond the matrix.
Bock F, Li S, Pozzi A, Zent R
Nat Rev Nephrol. 2024; 21(3):157-174.
PMID: 39643697
DOI: 10.1038/s41581-024-00906-1.
Rac1 GTPase Regulates the βTrCP-Mediated Proteolysis of YAP Independently of the LATS1/2 Kinases.
Palanivel C, Somers T, Gabler B, Chen Y, Zeng Y, Cox J
Cancers (Basel). 2024; 16(21).
PMID: 39518045
PMC: 11545309.
DOI: 10.3390/cancers16213605.
Overcoming Therapy Resistance in Colorectal Cancer: Targeting the Rac1 Signaling Pathway as a Potential Therapeutic Approach.
Anselmino L, Malizia F, Avila A, Cesatti Laluce N, Mamberto M, Zanotti L
Cells. 2024; 13(21.
PMID: 39513883
PMC: 11545287.
DOI: 10.3390/cells13211776.
Disulfidptosis: a novel cell death modality induced by actin cytoskeleton collapse and a promising target for cancer therapeutics.
Li T, Song Y, Wei L, Song X, Duan R
Cell Commun Signal. 2024; 22(1):491.
PMID: 39394612
PMC: 11470700.
DOI: 10.1186/s12964-024-01871-9.
The Rac1-PAK1-Arp2/3 signaling axis regulates CHIKV nsP1-induced filopodia and optimal viral genome replication.
Aiqui-Reboul-Paviet O, Bakhache W, Bernard E, Holsteyn L, Neyret A, Briant L
J Virol. 2024; 98(10):e0061224.
PMID: 39297643
PMC: 11495065.
DOI: 10.1128/jvi.00612-24.
RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.
Li Y, Gu A, Yang L, Wang Q
J Cancer Res Clin Oncol. 2024; 150(9):418.
PMID: 39264423
PMC: 11393158.
DOI: 10.1007/s00432-024-05933-w.
Genetic Variants in the Gene Are Associated with Ramon Syndrome and Hereditary Gingival Fibromatosis.
Kularbkaew T, Thongmak T, Sandeth P, Durward C, Vittayakittipong P, Duke P
Int J Mol Sci. 2024; 25(16).
PMID: 39201553
PMC: 11354241.
DOI: 10.3390/ijms25168867.
Fam49b dampens TCR signal strength to regulate survival of positively selected thymocytes and peripheral T cells.
Park C, Guan J, Rhee P, Gonzalez F, Lee H, Park J
Elife. 2024; 13.
PMID: 39158947
PMC: 11333044.
DOI: 10.7554/eLife.76940.
Presynaptic Rac1 in the hippocampus selectively regulates working memory.
Kim J, Bustamante E, Sotonyi P, Maxwell N, Parameswaran P, Kent J
Elife. 2024; 13.
PMID: 39046788
PMC: 11268886.
DOI: 10.7554/eLife.97289.
Peroxiporins in Triple-Negative Breast Cancer: Biomarker Potential and Therapeutic Perspectives.
Bijelic A, Silovski T, Mlinaric M, cipak Gasparovic A
Int J Mol Sci. 2024; 25(12).
PMID: 38928364
PMC: 11203578.
DOI: 10.3390/ijms25126658.
The Small G-Protein Rac1 in the Dorsomedial Striatum Promotes Alcohol-Dependent Structural Plasticity and Goal-Directed Learning in Mice.
Hoisington Z, Salvi A, Laguesse S, Ehinger Y, Shukla C, Phamluong K
J Neurosci. 2024; 44(29.
PMID: 38886056
PMC: 11255432.
DOI: 10.1523/JNEUROSCI.1644-23.2024.
LOX-1 in Cardiovascular Disease: A Comprehensive Molecular and Clinical Review.
Sanchez-Leon M, Loaeza-Reyes K, Matias-Cervantes C, Mayoral-Andrade G, Perez-Campos E, Perez-Campos-Mayoral L
Int J Mol Sci. 2024; 25(10).
PMID: 38791315
PMC: 11121106.
DOI: 10.3390/ijms25105276.
Using Omics to Identify Novel Therapeutic Targets in Heart Failure.
Lteif C, Huang Y, Guerra L, Gawronski B, Duarte J
Circ Genom Precis Med. 2024; 17(3):e004398.
PMID: 38766848
PMC: 11187651.
DOI: 10.1161/CIRCGEN.123.004398.
Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions.
Chen J, Ma B, Yang Y, Wang B, Hao J, Zhou X
Biomark Res. 2024; 12(1):45.
PMID: 38685115
PMC: 11059647.
DOI: 10.1186/s40364-024-00593-x.
Tumorigenesis driven by the BRAF oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion.
Gadal S, Boyer J, Roy S, Outmezguine N, Sharma M, Li H
bioRxiv. 2024; .
PMID: 38659913
PMC: 11042182.
DOI: 10.1101/2023.11.21.568071.